Focused Radiation Before or After Surgery for Cancer That Spread to the Brain
Official title: Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on .
The short version
This trial tests whether focused radiation works better before or after brain surgery.
Read our full plain-language summary
What the trial team says
This phase III trial studies the side effects and how well stereotactic radiosurgery (SRS) works before or after surgery in patients with tumors that has spread to the brain or that can be removed by surgery. Stereotactic radiosurgery is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor and may cause less damage to normal tissue.
Key facts
- Registry number
- NCT03750227
- Stage of testing
- Phase 3
- Conditions studied
- Malignant Solid Neoplasm, Metastatic Malignant Neoplasm in the Brain
Where it is running
This trial lists 4 sites.
-
Arizona
- Mayo Clinic in Arizona (Scottsdale)
-
Florida
- Mayo Clinic in Florida (Jacksonville)
-
Maryland
- NIH Clinical Center (Bethesda)
-
Minnesota
- Mayo Clinic in Rochester (Rochester)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.